Cite
Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells.
MLA
Wang, Shijie, et al. “Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 Efficiently Kill Glioblastoma and Cancer Stem Cells.” Journal of Translational Medicine, vol. 21, no. 1, July 2023, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12967-023-04330-0.
APA
Wang, S., Wei, W., Yuan, Y., Sun, B., Yang, D., Liu, N., & Zhao, X. (2023). Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells. Journal of Translational Medicine, 21(1), 1–13. https://doi.org/10.1186/s12967-023-04330-0
Chicago
Wang, Shijie, Wenwen Wei, Yuncang Yuan, Bin Sun, Dong Yang, Nan Liu, and Xudong Zhao. 2023. “Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 Efficiently Kill Glioblastoma and Cancer Stem Cells.” Journal of Translational Medicine 21 (1): 1–13. doi:10.1186/s12967-023-04330-0.